Prostate Cancer - May 31, 2018 Edition

Health News and Information - News Medical

May 31, 2018     Prostate Cancer     The latest prostate cancer news from News Medical

Study finds way to better treat men with locally advanced prostate cancer   A new study published today has found a way to identify men with locally advanced prostate cancer who are less likely to respond well to radiotherapy.

New research may help elucidate racial differences in prostate cancer   New research published in Molecular Oncology may help explain why African American men are at a higher risk of being diagnosed with prostate cancer and a higher risk of dying from the disease compared with European American men.         Study uncovers promising new line of attack against aggressive prostate cancer   UC San Francisco researchers have discovered a promising new line of attack against lethal, treatment-resistant prostate cancer. Analysis of hundreds of human prostate tumors revealed that the most aggressive cancers depend on a built-in cellular stress response to put a brake on their own hot-wired physiology.

Researchers screen molecules that could be potential target for prostate cancer treatments   Cancer researchers at the University of Bath have measured systematically how efficient molecules are at suppressing the activity of a protein associated with prostate and other cancers. The molecules could eventually be developed into new anti-cancer drugs.       Should MRI be Used to Diagnose Prostate Cancer?   Magnetic resonance imaging (MRI) is a non-invasive diagnostic technique for producing three-dimensional scans of body organs.       Automated bone scan index offers accurate, speedy prognostic information about prostate cancer   A software tool to automatically calculate how extensively bones have been infiltrated by prostate cancer is both accurate and speedy, capturing key prognostic information related to survival and the development of symptoms over time.       New blood test could help avoid more than 40% of prostate biopsies, study finds   A multi-center study that validates the clinical performance of IsoPSA - a new blood test that has proven to be more accurate in predicting overall risk of prostate cancer than standard prostate-specific antigen - will be presented during a special press conference at the 13th Annual Meeting of the American Urological Association on May 18 in San Francisco.

Website: www.news-medical.net Email: info@news-medical.net Telephone: +44 (0)161 457 7150 AZoNetwork UK Ltd. NEO, 4th Floor 9 Charlotte Street, Manchester M1 4ET, UK